Chronic administration of adenosine A3 receptor agonist and cerebral ischemia: Neuronal and glial effects

European Journal of Pharmacology

Volumn 367, Issue 2-3, 1999, Pages 157-163

  Von Lubitz, Dag K J E ^a   Lin, Rick C S ^b   Boyd, Mellonie ^a   Norbert Bischofberger, ^c   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c GILEAD SCIENCES   (United States)

Author keywords

Adenosine A3 receptor; Gerbil; GFAP (glial fibrillary acidic protein); Ischemia; MAP 2 (microtubule associated protein); Nitric oxide (NO); Synthase

Indexed keywords

ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLIC AMP; GLIAL FIBRILLARY ACIDIC PROTEIN; N6 (3 IODOBENZYL) 5' N METHYLCARBOXOAMIDOADENOSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GERBIL; GLIA CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ANIMALS; BRAIN CHEMISTRY; CAROTID ARTERIES; COLORING AGENTS; FEMALE; GERBILLINAE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MICROTUBULE-ASSOCIATED PROTEINS; NITRIC OXIDE SYNTHASE; RECEPTORS, PURINERGIC P1; TIME FACTORS;

EID: 0033010703     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00977-7     Document Type: Article

References (42)

1. Abbracchio M.P., Brambilla R., Cerutti S., Kim H.O., Von Lubitz D.K.J.E., Jacobson K.A., Cattabeni F. G Protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol. Pharmacol. 48:1995;1038-1045.
2. Abbracchio, M.P., Ceruti, S., Burnstock, G., Cattabeni, F., 1995b. Purinoceptors on glial cells of the central nervous system: functional and pathologic implications. In: Belardinelli, L., Pelleg, A. (Eds.), Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, Kluwer Academic Publishers, Boston, pp. 271-280.
3. Aoki E., Takeuchi I.K., Shoji R. Nitric oxide: an attractive signalling molecule. Acta Histochem. Cytochem. 2:1995;97-100.
4. Ceruti S., Barbieri D., Franceschi C., Giammaroli A.M., Rainaldi G., Malorni W., Kim H.O., Von Lubitz D.K.J.E., Jacobson K.A., Cattabeni F., Abbracchio M.P. Effects of adenosine A3 receptor agonists on astrocytes: induction of cell protection at low and cell death at high concentrations. Drug. Dev. Res. 3:1996;177.
5. Dalkara T., Yoshida T., Irikura K., Moskowitz M.A. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology. 33:1994;1447-1452.
6. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cell culture. Proc. Natl. Acad. Sci. U.S.A. 88:1991;6368-6371.
7. Elias H., Hyde D.M. An elementary introduction to stereology. Am. J. Anat. 159:1980;412-446.
8. Endoh, Maiese K., Wagner J. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651:1994;92-100.
9. Goodman S.R., Zagon I.S. The neural cell spectrin skeleton: a review. Am. J. Physiol. 250:1986;347-360.
10. Hope B.T., Mitchell G.J., Knigg K.M., Vincent S.R. Neuronal NADP diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 88:1991;2811-2820.
11. Iadecola C., Pellegrino D.A., Moskowitz M.A., Lassen N. Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 14:1994;175-192.
12. Iadecola C., Xu X., Zhang F., el-Ferkany E.E., Ross M.E. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1:1995;52-59.
13. Kato H., Kogure K., Liu Y., Araki T., Itoyama Y. Induction of NADPH-diaphorase activity in the hippocampus in a rat model of cerebral ischemia and ischemic tolerance. Brain Res. 652:1994;71-75.
14. 6-benzyladenosine-5′-uronamides enhances selectivity for A3 adenosine receptors. J. Med. Chem. 21:1994;3614-3621.
15. Knowles R.G., Palacios M., Palmer R.M.J., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble gunanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5159-5162.
16. Kohno, Y., Sei, Y., Koshiba, M., Kim, H.O., Jacobson, K.A., 1996. Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A3 receptor agonists. Biochem. Biophys. Res. Commun. 219, 904, 910 (see also erratum in Biochem. Biophys. Res. Commun. 221, 849).
17. Kohno, Y., Sei, Y., Koshiba, M., Kim, H.O., Jacobson, K.A., 1996. Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A3 receptor agonists. Biochem. Biophys. Res. Commun. 219, 904, 910 (see also erratum in Biochem. Biophys. Res. Commun. 221, 849).
18. Lee R.J., Bajorek J.G., Lomax P. Similar anticonvulsive, but unique behavioural effects of opioid agonists in the seizure-sensitive Mongolian gerbil. Neuropharmacology. 23:1984;517-524.
19. Lin R.C.S., Matesic D.F., Marvin M., McKay R.D.G., Brüstle O. Re-expression of the intermediate filament nestin in reactive astrocytes. Neurobiol. Dis. 2:1995;79-85.
20. Li J., Chen S., Lin R.C.S., Smith S.S. Cerebellar nitric oxide synthase is expressed within granule cell patches innervated by specific mossy fiber terminals: a development profile. Dev. Neurosci. 19:1997;274-282.
21. Lin C.-S., Polsky K., Nadler J.V., Crain B. Selective neocortical and thalamic cell death in the gerbil after transient ischemia. Neuroscience. 2:1990;289-299.
22. Loesch A., Belai A., Burnstock G. An ultrastructural study of NADPH-diaphorase and nitric oxide synthase in the perivascular nerves and vascular endothelium of the rat basilar artery. J. Neurocytol. 23:1994;49-59.
23. Loskota, W.J., Lomax, P., Verity, M.A., 1974. A Stereotaxic Atlas of the Mongolian Gerbil Brain. Ann Arbor Sci. Publ., Ann Arbor, MI.
24. Matesic D.F., Lin R.C.S. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J. Neurochem. 63:1994;1012-1020.
25. Nagafuji T., Sugiyama M., Matsui T., Muto A., Naito S. Nitric oxide synthase in cerebral ischemia: possible contribution of nitric oxide synthase activation in brain microvessels to cerebral ischemic injury. Mol. Chem. Neuropathol. 26:1995;107-157.
26. Nakashima M.N., Yamashita K., Kataoka Y., Yamashita Y.S. Time course of nitric oxide synthase activity in neuronal, glial, and endothelial cells of rat striatum following focal cerebral ischemia. Cell Mol. Neurobiol. 15:1995;341-349.
27. Petito C.K., Babiak T. Early proliferative changes in astrocytes in postischemic noninfarcted rat brain. Ann. Neurol. 11:1982;510-518.
28. Petito C.K., Morgello S., Felix J.C., Lesser M.L. The two patterns of reactive astrocytosis in postischemic rat brain. J. Cereb. Blood Flow Metab. 10:1990;850-859.
29. Ramkumar V., Stiles G.L., Beaven M.A., Ali H. The A3 AR is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268:1993;16887-16890.
30. Šestan N., Kostovi I. Histochemical localization of nitric oxide synthase in the CNS. Trends Pharmacol. Sci. 3:1994;106.
31. Shapira S., Kadar T., Weissman B.A. Dose-dependent effect of nitric oxide synthase inhibition following transient forebrain ischemia in gerbils. Brain Res. 668:1994;80-84.
32. 2+) in hypoxia and ischemia in rat brain in vivo. J. Gen. Physiol. 95:1990;837-866.
33. Sparrow J.R. Inducible nitric oxide synthase in the central nervous system. J. Mol. Neurosci. 5:1995;219-229.
34. 3 receptor and brain: a culprit, a hero, or merely yet another receptor. In: Trembly, B., Slikker, W. (Eds.), Neuroprotective Agents: Clinical and Experimental Aspects II. Ann. New York Acad. Sci. 825, 49-67.
35. Von Lubitz D.K.J.E. Adenosine A3 receptor and brain: a culprit, a hero, or merely yet another receptor. Proc. N.Y. Acad. Sci. 825:1997;49-67.
36. Von Lubitz D.K.J.E., Diemer N.H. Complete cerebral ischemia in the rat: an ultrastructural and stereological analysis of the distal stratum radiatum in the hippocampal CA-1 region. Neuropathol. Appl. Neurobiol. 8:1982;197-215.
37. Von Lubitz D.K.J.E., Dambrosia J.M., Redmond D.J. Protective effect of cyclohexyl adenosine in treatment of cerebral ischemia in gerbils. Neuroscience. 2:1989;451-462.
38. Von Lubitz D.K.J.E., Lin R.C.-S., Popik P., Carter M.F., Jacobson K.A. Adenosine A3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263:1994;59-67.
39. Von Lubitz, D.K.J.E., Lin, R.C.-S., Paul, I.A., Beenhakker, M., Boyd, M., Bischofberger, N., Jacobson, K.A., 1996. Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils. Eur. J. Pharmacol., 171-179.
40. Wallace M.N. NADP-diaphorase activity in activated astrocytes representing inducible nitric oxide synthase. Methods Enzymol. 268:1996;497-503.
41. 2+/calmodulin-dependent protein kinase II and phosphorylation of intermediate filament proteins by stimulation of glutamate receptors in cultured cortical astrocytes. J. Biol. Chem. 261:1994;5428-5439.
42. Zhou Q.Y., Li C.Y., Olah M.E., Johnson R.A., Stiles G.L., Civelli O. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7432-7436.